France Cardiovascular Ultrasound Market Expected to Reach $252.9 Million by 2030

According to a new report published by Allied Market Research, titled, “France Cardiovascular Ultrasound Market by Clinical Application, Technology, Device Display, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2021–2030,"

The France cardiovascular ultrasound market was valued at $162.97 million in 2020, and is projected to reach $252.90 million by 2030, registering a CAGR of 4.7% from 2021 to 2030. Cardiac ultrasound, also known as echocardiography, refers to the ultrasound imaging of the heart. It examines the structure and function of the heart and related vessels. Image analysis is driven by technology, as diagnosing heart disease requires a fairly detailed view of the heart and blood movement. Therefore, ultrasound systems can be highly specialized for this area. It is a graphic outline of the heart's movement.

The key factors that boost the growth of the France cardiovascular ultrasound market include increased advantages of echocardiography over invasive cardiac diagnostic procedures and surge in incidence of cardiovascular diseases (CVDs). In addition, this technology is widely accepted among patients as it is non-invasive, hence shortens the stay at hospitals, which fuels the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. The ultrasound device manufacturing was disturbed in 2020 due to the slowdown of distribution chain of raw materials. Moreover, the manpower needed for the manufacturing plants could not come to work due to lockdown imposed, which shut down the manufacturing plants of the ultrasound devices. Overall impact of the COVID-19 pandemic on the France cardiovascular ultrasound market was recorded to be negative owing to the factors such as disturbance in the distribution chain, financial problems, scarcity of laborers at manufacturing plants, and decrease in the number of ultrasound diagnosis performed amid the pandemic. However, this situation is expected to change post COVID-19 pandemic in the coming years.

The France cardiovascular ultrasound market is segmented into clinical application, technology, device display, age group, and end user.

On the basis of clinical application, the market is categorized into diagnostic cardiology, interventional cardiology and vascular diagnostic. The diagnostic cardiology segment dominated the market in 2020, and is anticipated to continue this trend during the forecast period. Key factors such as increase in the prevalence of heart diseases, development of new &advanced cardiovascular ultrasound devices, and rise in focus toward diagnosis through ultrasound devices are expected to drive the growth of the segment.

By technology, it is classified into 2D, 3D & 4D, and Doppler imaging. The 2D segment accounted for maximum France cardiovascular ultrasound market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to surge in the geriatric population and change in lifestyle of the people, which are anticipated to drive the market growth. However, the 3D & 4D segment exhibits fastest growth from 2021 to 2030 owing to increase in the number of heart patients and rise in the awareness of diagnosis via ultrasound devices. Moreover, availability of large number of advanced hospitals, presence of skilled medical professionals, large number of ambulatory centers, and wide usage of medical nonwoven products are anticipated to drive the growth of the segment.

By device display, it is classified into color display, and black &white display. The color display segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increasing advantages of echocardiography over invasive cardiac diagnostic procedures, and surge in incidence of cardiovascular diseases (CVDs), which are projected to foster the France cardiovascular ultrasound market growth.

By age group, it is classified into adult and pediatric. The adult segment accounted for maximum France cardiovascular ultrasound market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increasing population of adult people and rise in incidence of cardiovascular diseases (CVDs) in that age group that are anticipated to drive the market growth.

By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers. The public hospitals segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increase in the number of hospitals and surge in number of government initiatives for the treatment. However, the cardiology centers segment exhibits fastest growth from 2021 to 2030 owing to rise in the number of healthcare center sand increase in incidences of heart diseases. Moreover, availability of number of advanced hospitals, presence of skilled professionals, and wide usage of ultrasound are anticipated to drive the growth of the segment.

Key Findings Of The Study

• By clinical application, the diagnostic cardiology segment held the largest France cardiovascular ultrasound market share in 2020, and is expected to remain dominant throughout the forecast period.
• According to technology, the 2D segment exhibits largest market share, and is expected to remain dominant throughout the forecast period.
• According to device display, the color display segment exhibits largest France cardiovascular ultrasound market share, and is expected to remain dominant throughout the forecast period.
• According to age group, the adult segment exhibits fastest growth, and is expected to grow at a CAGR of 4.9% from 2021 to 2030.
• According to end user, the cardiology centers segment exhibits fastest growth, and is expected to grow at a CAGR of 5.3% from 2021 to 2030.